BioArctic AB's (publ) (STO: BIOA B) partner Eisai today published the preliminary global revenue for Leqembi during the third quarter 2025, in conjunction with their partner Biogen's third quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback